Skip to main content

Hepatobiliary Disease and Anaesthesia

  • Chapter
Liver and Biliary Tract Surgery

Abstract

The term hepatobiliary disease refers to acute or chronic disorders of the hepatic cells and/or the biliary tract. In this chapter are firstly described the clinical forms of the hepatobiliary disease and, secondly, the pathophysiologic mechanisms that are responsible for hepatic cell damage. Since surgery in patients with pre-existing severe hepatobilary disease is associated with significant morbidity and mortality rates, the anaesthesiologist should be able to diagnose and evaluate hepatic dysfunction during the perioperative period. Even with careful attention to history and symptoms, some cases of liver disease can be misdiagnosed. However, in most cases the cause of misdiagnosis results from failure to ask simple questions or to look for obvious findings on physical examination. Laboratory investigation of the hepatobiliary disease lacks in specificity in defining a certain liver disease. Instead of this, laboratory testing of liver function helps to differentiate the diagnosis among hepatocellular injury, impaired hepatocellular synthetic function and cholestasis

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hoskins JD. Liver disease in the geriatric patient (Review). Vet Clin North Am Small Anim Pract 2005; 35:617–34.

    Article  PubMed  Google Scholar 

  2. Krumberger J. When the liver fails (Review). RN 2002; 65:26–9; quiz 30.

    PubMed  Google Scholar 

  3. Blum HE, Farthmann EH. The patient with hepatopathy. Chirurg 1997; 68:763–9.

    Article  PubMed  CAS  Google Scholar 

  4. Riordan SM, Williams R. Fulminant hepatic failure. Clin Liver Dis 2000; 4:25–45.

    Article  PubMed  CAS  Google Scholar 

  5. Franzetta M, Raimondo D, Giammanco M. Prognostic factors of cirrhotic patients in extra-hepatic surgery. Minerva Chir 2003; 58:541–4.

    PubMed  CAS  Google Scholar 

  6. Selmi C, Ichiki Y, Invernizzi P. The enigma of primary biliary cirrhosis. Clin Rev Allergy Immunol 2005; 28:73–81.

    Article  PubMed  CAS  Google Scholar 

  7. Oo YH, Neuberger J. Options for treatment of primary biliary cirrhosis. Drugs 2004; 64:2261–71.

    Article  PubMed  CAS  Google Scholar 

  8. Gentilini P, Vizzutti F, Gentilini A. Ascites and hepatorenal syndrome. Eur J Gastroenterol Hepatol 2001; 13:313–6.

    Article  PubMed  CAS  Google Scholar 

  9. Alizadeh AH, Fatemi SR, Mirzaee V. Clinical features of he-patopulmonary syndrome in cirrhotic patients. World J Gastroenterol 2006; 12:1954–6.

    PubMed  Google Scholar 

  10. Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2006; 43:1187–90.

    Article  PubMed  CAS  Google Scholar 

  11. Bhatia AS, Mihas AA. Cholestatic liver disease. Recognizing the clinical signs. Postgrad Med 2006; 119:67–75 and 82.

    PubMed  Google Scholar 

  12. Perez Fernandez T, Lopez Serrano P, Tomas E. Diagnostic and therapeutic approach to cholestatic liver disease. Rev Esp Enferm Dig 2004; 96:60–73.

    Article  PubMed  CAS  Google Scholar 

  13. Siegmund SV, Brenner DA. Molecular pathogenesis of alcohol-induced hepatic fibrosis. Alcohol Clin Exp Res 2005; 29(11 Suppl):102S–109S.

    Article  PubMed  CAS  Google Scholar 

  14. Sun CK, Zhang XY, Sheard PW. Change in mitochondrial membrane potential is the key mechanism in early warm hepatic ischemia-reperfusion injury. Microvasc Res 2005; 70:102–10.

    Article  PubMed  CAS  Google Scholar 

  15. Thurman RG. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998; 275:G605–11.

    PubMed  CAS  Google Scholar 

  16. Sierra F, Torres D. A concise and structured review of drug-induced toxic hepatic disease. Ann Hepatol 2004; 3:18–25.

    PubMed  Google Scholar 

  17. Patel T. Apoptosis in hepatic pathophysiology. Clin Liver Dis 2000; 4:295–317.

    Article  PubMed  CAS  Google Scholar 

  18. Yamada S, Tomiya T, Yamaguchi Y. Activation of hepatic macrophages contributes to hepatic necrosis after post-ischemic reperfusion in alcoholic fatty liver. Hepatol Res 2003; 26:209–16.

    Article  PubMed  CAS  Google Scholar 

  19. Cormack CR, Sudan S, Addison R. The pharmacokinetics of a single rectal dose of paracetamol (40mg × kg-1) in children with liver disease. Paediatr Anaesth 2006; 16:417–23.

    Article  PubMed  CAS  Google Scholar 

  20. Minoda Y, Kharasch ED. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P450 2A6 (CYP2A6). Anesthesiology 2001; 95:509–14.

    Article  PubMed  CAS  Google Scholar 

  21. Topal A, Gul N, Ilcol Y. Hepatic effects of halothane, isoflurane or sevoflurane anaesthesia in dogs. J Vet Med A Physiol Pathol Clin Med 2003; 50:530–3.

    PubMed  CAS  Google Scholar 

  22. Garg RK. Anesthetic considerations in patients with hepatic failure. Int Anesthesiol Clin 2005; 43:45–63.

    Article  PubMed  Google Scholar 

  23. Prema Raj J. The liver in surgery. Singapore Med J 2006; 47:106–8.

    PubMed  CAS  Google Scholar 

  24. Poon RT, Fan ST. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 2005; 12:31–7.

    Article  PubMed  Google Scholar 

  25. Franzetta M, Raimondo D, Giammanco M. Prognostic factors of cirrhotic patients in extra-hepatc surgery. Minerva Chir 2003; 58:541–4.

    PubMed  CAS  Google Scholar 

  26. Suman A, Carey WD. Assessing the risk of surgery in patients with liver disease. Cleve Clin J Med 2006; 73:398–404.

    PubMed  Google Scholar 

  27. Bell CL, Jeyarajah DR. Management of the cirrhotic patient that needs surgery. Curr Treat Options Gastroenterol 2005; 8:473–80.

    Article  PubMed  Google Scholar 

  28. Kocher HM, Tekkis PP, Gopal P. Risk-adjustment in hepatobiliary pancreatic surgery. World J Gastroenterol 2005; 11:2450–5.

    PubMed  Google Scholar 

  29. Bizouarn P, Ausseur A, Desseigne P. Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann Thorac Surg 1999; 67:1334–8.

    Article  PubMed  CAS  Google Scholar 

  30. Newsome PN, Henderson NC, Germain L. Prothrombin time to assess fulminant hepatic failure. Lancet, 2001; 358:2172.

    Article  PubMed  CAS  Google Scholar 

  31. Del Olmo JA, Flor-Lorente B, Flor-Civera B. Risk factors for nonhepatic surgery in patients with cirrhosis. World J Surg 2003; 27:647–52.

    Article  PubMed  Google Scholar 

  32. Farnsworth N, Fagan SP, Berger DH. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004; 188:580–3.

    Article  PubMed  Google Scholar 

  33. Shetty K, Rybicki L, Carey WD. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997; 25:1049–53.

    Article  PubMed  CAS  Google Scholar 

  34. Kumle B, Boldt J, Suttner SW. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg 2003; 75:1558–64.

    Article  PubMed  Google Scholar 

  35. Chetty G, Sharpe DA, Nandi J. Liver blood flow during cardiac surgery. Perfusion 2004; 19:153–6.

    Article  PubMed  Google Scholar 

  36. Valla DC. Vascular disorders of the liver. Acta Gastroenterol Belg 2003; 66:294–7.

    PubMed  Google Scholar 

  37. Kharasch ED, Hankins DC, Fenstamaker K. Human halothane metabolism, lipid peroxidation and cytochromes P (450) 2A6 and P(450)3A4. Eur J Clin Pharmacol 2000; 55:853–9.

    Article  PubMed  CAS  Google Scholar 

  38. Suttner SW, Schmidt CC, Boldt J. Low-flow desflurane and sevoflurane anesthesia minimally affect hepatic integrity and function in elderly patients. Anesth Analg 2000; 91:206–12.

    Article  PubMed  CAS  Google Scholar 

  39. Njoku D, Laster MJ, Gong DH. Biotrasformation of halothane, enflurane, isoflurane and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 1997; 84:173–8.

    Article  PubMed  CAS  Google Scholar 

  40. Tung D, Yoshida EM, Wang CS. Severe desflurane hepato-toxicity after colon surgery in an elderly patient. Can J Anaesth 2005; 52:133–6.

    Article  PubMed  Google Scholar 

  41. Malnick SD, Mahlab K, Borchardt J. Acute cholestatic hepatitis after exposure to isoflurane. Ann Pharmacother 2002; 36:261–3.

    Article  PubMed  Google Scholar 

  42. Hohne C, Donauber B, Kaisers U. Opioids during anesthesia in liver and renal failure. Anaesthesist 2004; 53:291–303.

    Article  PubMed  CAS  Google Scholar 

  43. Raucoules-Aime M, Kaidomar M, Levron JC. Hepatic disposition of alfentanil and sufentanil in patients undergoing orthotopic liver trasplantation. Anesth Analg 1997; 84:1019–24.

    Article  PubMed  CAS  Google Scholar 

  44. van Miert MM, Eastwood NB, Boyd AH. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997; 44:139–44.

    Article  PubMed  Google Scholar 

  45. Silva MA, Muralidharan V, Mirza DF. The management of coagulopathy and blood loss in liver surgery. Semin Hematol 2004; 41(Suppl 1):132–9.

    Article  PubMed  Google Scholar 

  46. Silva MA, Wong T. Gallstones in chronic liver disease. J Gastrointest Surg 2005; 9:739–46.

    Article  PubMed  Google Scholar 

  47. Poon RT. Recent advances in techniques of liver resection. Surg Technol Int 2004; 13:71–7.

    PubMed  Google Scholar 

  48. Keegan MT, Plevak DJ. Preoperative assessment of the patient with liver disease. Am J Gastroenterol 2005; 100:2116–27.

    Article  PubMed  Google Scholar 

  49. Lauterburg BH. Assessment of liver function prior to hepatic resection. Swiss Surg 1999; 5:92–6.

    Article  PubMed  CAS  Google Scholar 

  50. Melendez JA, Arslan V, Fischer ME. Perioperative outcomes of major hepatic resections under low central venous pressure anaesthesia: blood loss, blood transfusion and the risk of post-operative renal dysfunction. J Am Coll Surg 1998; 187:620–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this chapter

Cite this chapter

Georgakis, P., Rizzotti, L., Katsouli-Liapis, I. (2006). Hepatobiliary Disease and Anaesthesia. In: Karaliotas, C.C., Broelsch, C.E., Habib, N.A. (eds) Liver and Biliary Tract Surgery. Springer, Vienna. https://doi.org/10.1007/978-3-211-49277-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-49277-2_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-49275-8

  • Online ISBN: 978-3-211-49277-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics